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Introduction
Antibody engineering allows proper design of improved
properties in antibody products such as a high binding
affinity, stable biophysical properties and low immuno-
genicity. Besides these obvious features improved by ele-
gant design the primary amino acid sequence also has
tremendous effects on the performance of the expression
host itself influencing cell culture parameters including
specific productivities and growth rates therefore having
major impact on the finally obtained antibody expression
titers [1]. By understanding the underlying mechanisms
how certain primary sequence combinations influence
culture performance in conjunction with biophysical fea-
tures of the antibody protein, we might rationally
improve the production process of these expensive but
essential biotherapeutic products.
Many different antibody variants were expressed in our
group in different projects based on various isotypes. For
several antibody variable regions we could observe a direct
correlation of advantageous cell performance and a high
degree of similarity to the closest human germline
sequence of the respective mature antibody leading to
higher specific productivities. However, the fundamental
principles of these consistent observations and the correla-
tion of cell behavior and biophysical product properties
remain quite elusive. Therefore, in this project we aim to
set the proper foundations to investigate the generalization
of a concept to improve cell performance and antibody
expression based on the primary sequence at a high ger-
minality degree (Figure 1). To have proper control of trans-
gene integration locus, gene copy numbers and mRNA
transcript level a suitable host for recombinase-mediated
cassette exchange (RMCE) was developed to compare dif-
ferent antibody variants under isogenic conditions.
Materials and methods
All cell lines (CHO-K1, DUKX-B11) were grown under
serum- and protein-free conditions in chemically defined
media in suspension using shaker flasks. Transfections
were performed with the cationic 25kDa linear polymer
polyethylenimine (PEI). Stable subclones were either gen-
erated by limited dilution subcloning or fluorescence-
activated cell sorting (FACS).Germline antibody sequences
were identified by the IgBlast program. Variable antibody
sequences were synthesized and cloned into vectors con-
taining leader and constant antibody regions.
For recombinase-mediated cassette exchange a CMV
(for DUKX-B11) or CAGGS (for CHO-K1) promoter
was placed 5’ upstream of the first flippase recognition
target site to establish a promoter trap in the parental
RMCE-cassette. A selection/reporter marker was placed
in-between two heterospecific FRT sites harboring a
gfp/thymidine-kinase/neomycin-phosphotransferase
fusion protein. Antibody producing cells were developed
after recombination with the reporter marker by nega-
tive selection with ganciclovir. Antibody product was
purified by protein A chromatography.
Results
The observed expression levels in cell cultures are influ-
enced by many different parameters that should be con-
trolled for a valid comparison of different antibody
variable sequences. Besides different host cell lines and
media formulations our group also has standardized fer-
mentation process protocols and biophysical analytical
tools for in-depth investigations of possible correlation
between cell culture performance, product quality attri-
butes and expression levels. Recently, we also engineered a
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CHO DUKX-B11 host cell line suitable for recombinase-
mediated cassette exchange (RMCE) [2] to control the
integration locus by targeted gene integration leading to
equal gene copy numbers (GCN) and mRNA levels
between different subclones or even between different
antibody variants [3]. Although we could demonstrate a
single RMCE-integration locus, facilitating the generation
of isogenic cell lines, the overall productivity remains rela-
tively low. Therefore a second generation RMCE host cell
line was designed based on CHO-K1 using the CAGGS
promoter as a promoter-trap. To analyze a panel of low
expressing antibodies in comparison to germline antibo-
dies the primary amino acid sequence was aligned to the
closest human germline sequence. The low expressing
anti-HIV antibodies 2F5, 2G12 and 4B3, as well as the
therapeutic anti-IL12/23 antibody Ustekinumab show
quite low levels of homology to its closest human germ-
lines (germinality) (Figure 1B). Based on the aligned germ-
line sequences novel germline antibodies were constructed
by combining the respective human germline sequences
(236/14, 353/11, 136/63 and 554/12). This panel of 8 anti-
bodies, spanning anti-HIV or therapeutic antibodies as
well as kappa and lambda light chain sequences, will be
expressed under isogenic and standardized conditions to
investigate critical cell culture parameters such as specific
productivity (qP) and growth rates (µ), product titer, meta-
bolism, gene copy number, mRNA transcript level or
intracellular product content. Additionally, enough mate-
rial will be expressed based on the improved RMCE host
cell line for proper investigation of biophysical properties
of the antibody molecules such as thermal and chemical
stability, aggregation and oligomer formation propensity
or glycosylation profiles.
Conclusions
An improved RMCE host cell line and an antibody panel
consisting of versatile variable regions including mature
antibodies and respective germline antibody sequences
were constructed for in-depth analysis of cell culture
parameters and biophysical properties evoked by differ-
ent degrees of germinality. By understanding the underly-
ing principles it should be possible to improve antibody
cell culture processes and biophysical features by means
of proper antibody engineering to optimize the primary
antibody sequence.
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Figure 1 Observed correlation of specific productivity and sequence identity to the closest human germline sequence (germinality)
(A). Antibody expression levels are influenced by several factors. Recombinase-mediated cassette exchange was applied to control for gene
copy number and mRNA transcript level. Low expressing antibody variants (2F5, 4B3 and 2G12) were compared to its closest human germline
sequence together with a therapeutic antibody (Ustekinumab) with low degree of germinality (B). Respective germline antibody variants were
constructed by combination of germline V-, D- and J-segments.
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